A Study Of Pembrolizumab In Combination With Trastuzumab-DM1

NCT03032107 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: T-DM1
DRUG: Pembrolizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]